This Article Full Text (PDF) Supplementary Material References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Satoh, J. Articles by Yamamura, T Search for Related Content PubMed PubMed Citation Articles by Satoh, J. Articles by Yamamura, T Pubmed/NCBI databases Medline Plus Health Information Multiple Sclerosis Social Bookmarking                         What's this?

Molecular network of the comprehensive multiple sclerosis brain-lesion proteome

Department of Bioinformatics and Molecular Neuropathology, Meiji Pharmaceutical University, Tokyo, Japan; Department of Immunology, National Institute of Neuroscience, NCNP, Tokyo, Japan satoj{at}my-pharm.ac.jp

H Tabunoki

Department of Bioinformatics and Molecular Neuropathology, Meiji Pharmaceutical University, Tokyo, Japan

T Yamamura

Department of Immunology, National Institute of Neuroscience, NCNP, Tokyo, Japan

Background

A recent proteomics study of multiple sclerosis (MS) lesion-specific proteome profiling clearly revealed a pivotal role of coagulation cascade proteins in chronic active demyelination. However, among thousands of proteins examined, nearly all of remaining proteins are yet to be characterized in terms of their implications in MS brain-lesion development.

Methods

By the systems biology approach using four different pathway analysis tools of bioinformatics, we studied molecular networks and pathways of the proteome dataset of acute plaques, chronic active plaques (CAP), and chronic plaques (CP).

Results

The database search on Kyoto Encyclopedia of Genes and Genomes (KEGG) and protein analysis through evolutionary relationships (PANTHER) indicated the relevance of extracellular matrix (ECM)–mediated focal adhesion and integrin signaling to CAP and CP proteome. KeyMolnet disclosed a central role of the complex interaction among diverse cytokine signaling pathways in brain-lesion development at all disease stages, as well as a role of integrin signaling in CAP and CP. Ingenuity pathway analysis (IPA) identified the network constructed with a wide range of ECM components, such as collagen, type I 1, type I 2, type VI 2, type VI 3, fibronectin 1, fibulin 2, laminin 1, vitronectin, and heparan sulfate proteoglycan, as one of the networks highly relevant to CAP proteome.

Conclusions

Although four distinct platforms produced diverse results, they commonly suggested a role of ECM and integrin signaling in development of chronic lesions of MS. These in silico observations indicate that the selective blockade of the interaction between ECM and integrins in brain lesions in situ would be a target for therapeutic intervention in MS.

Key Words: extracellular matrix • multiple sclerosis • pathway analysis • proteome • systems biology

Multiple Sclerosis, Vol. 15, No. 5, 531-541 (2009)
DOI: 10.1177/1352458508101943


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				M. Han and L Steinman Systems biology for identification of molecular networks in multiple sclerosis Multiple Sclerosis, May 1, 2009; 15(5): 529 - 530. [PDF]